IP Library Granted Patent US 7,833,267
Granted Patent B2
US 7,833,267 · App. 12/257,720 · Granted Nov 16, 2010

Methods and systems for modifying vascular valves

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,833,267
App. No.
12/257,720
Granted
Nov 16, 2010
Kind
B2
Abstract

Described are methods and systems for modifying vascular valves in order to reduce retrograde blood flow through the valves. Preferred methods include connecting vascular valve leaflets with at least one remodelable material, such that the valve leaflets become fused by the ingrowth of the patient's native tissue. Preferred remodelable materials include collagenous extracellular matrix material, such as small intestine submucosa.

Claims (32)

1. A method for modifying a vascular valve in a patient, comprising:

accessing a vascular valve in the body of a patient; and

attaching a remodelable material to at least a first valve leaflet and a second valve leaflet in the vascular valve, the remodelable material effective upon implantation to become replaced by native patient tissue so as to provide a remodeled tissue spanning between the first valve leaflet and the second valve leaflet to fuse the first valve leaflet to the second valve leaflet.

2. The method of claim 1 , wherein said remodelable material comprises an extracellular matrix material.

3. The method of claim 2 , wherein said extracellular matrix material comprises submucosa, dura mater, pericardium, renal capsule membrane, or basement membrane.

4. The method of claim 1 , wherein said remodelable material comprises a bioabsorbable synthetic polymer.

5. The method of claim 1 , wherein said remodelable material is a hybrid of extracellular matrix material and bioabsorbable synthetic polymer.

6. The method of claim 2 , wherein said extracellular matrix material is in the form of a suture.

7. The method of claim 1 , wherein said remodelable material includes a portion positioned over a lip of the first valve leaflet and a lip of the second valve leaflet.

8. The method of claim 1 , wherein the remodeled tissue spanning between the first valve leaflet and the second valve leaflet is free from any foreign body component.

9. A method for modifying the flow of blood in a vascular vessel, comprising:

accessing a vascular valve in the body of a patient; and

connecting a first valve leaflet in the vascular valve to a second valve leaflet in the vascular valve with a material that is receptive to tissue ingrowth so as to promote native patient tissue to grow into the material to fuse the first valve leaflet to the second valve leaflet.

10. The method of claim 9 , wherein said first valve leaflet and said second valve leaflet are connected in a central region of each said leaflet.

11. The method of claim 9 , wherein said first valve leaflet and said second valve leaflet are connected in at least one location proximate a junction of each of said leaflets to a common wall of said vessel.

12. The method of either claim 9 , wherein said tissue ingrowth receptive material is connected to each valve leaflet at least in part by suture.

13. The method of either claim 9 , wherein said tissue ingrowth receptive material comprises a sheet of extracellular matrix material.

14. The method of either claim 9 , wherein said tissue ingrowth receptive material comprises a twisted band of mammalian submucosa.

15. The method of claim 9 , wherein said tissue ingrowth receptive material comprises a bioabsorbable synthetic polymer.

16. The method of claim 9 , wherein said tissue ingrowth receptive material includes a portion extending through at least one of said first valve leaflet and said second valve leaflet.

17. The method of claim 9 , wherein said tissue ingrowth receptive material includes a portion positioned on an exterior surface of said first valve leaflet between said first valve leaflet and the wall of said vessel.

18. A method for modifying a vascular valve in a patient, comprising:

accessing a vascular valve in the body of a patient; and

locating an extracellular matrix material in the vascular valve such that the extracellular matrix material contacts a first valve leaflet and extends therefrom to contact a second valve leaflet so as to promote native patient tissue to grow into the extracellular matrix material to fuse the first valve leaflet to the second valve leaflet.

19. The method of claim 18 , wherein said extracellular matrix material comprises an extracellular matrix sheet material harvested from a collagenous tissue source.

20. A method for modifying a vascular valve in a patient, comprising:

locating an extracellular matrix material in a vascular valve such that the extracellular matrix material contacts a first valve leaflet and extends therefrom to contact a second valve leaflet so as to promote native patient tissue to grow into the extracellular matrix material to fuse the first valve leaflet to the second valve leaflet, wherein said extracellular matrix material is delivered to said vascular valve with a delivery catheter.

21. The method of claim 20 , wherein said extracellular matrix material is secured to said first valve leaflet and said second valve leaflet.

22. The method of claim 21 , wherein securement of said extracellular matrix material to said first valve leaflet and said second valve leaflet comprises stapling.

23. The method of claim 18 , wherein said extracellular matrix material is placed between said first valve leaflet and said second valve leaflet and is secured with one or more staple, suture, and/or clip.

24. The method of claim 23 , wherein said extracellular matrix material comprises a gel.

25. The method of claim 23 , wherein said extracellular matrix material is small intestine submucosa and said clip comprises an extracellular matrix material.

Assignments (3)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2011
From: COOK INCORPORATED; WILSON-COOK MEDICAL INCORPORATED; VANCE PRODUCTS INCORPORATED; COOK VASCULAR INCORPORATED; SABIN CORPORATION
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 026287/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2008
From: FLAGLE, JACOB A.; CASE, BRIAN C.
To: COOK INCORPORATED
Reel/Frame 021746/0278 →